Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats

The Centers for Disease Control and Prevention provides support for domestic and global infrastructure to prevent and control infectious diseases that threaten the public’s health. The proposed cooperative agreement would fund organizations that represent professionals at the front line of preventing and controlling the spread of emerging and re-emerging infectious disease threats such as COVID-19, including clinicians, other healthcare professionals, healthcare systems, and other organizations and institutions responsible for infectious disease prevention and control in the United States. This NOFO is intended to establish a roster of organizations that would be pre-identified and pre-approved for rapid funding by CDC to address emerging and re-emerging public health threats. This NOFO will establish an Approved-But-Unfunded (ABU) list of grantees. This ABU list will be utilized by CDC to effectively respond to, manage, and address the identified public health threat, in partnership with national and regional organizations. Applications seeking to conduct activities outside the scope of the program activities will be deemed non-responsive and will not be considered. Under the proposed umbrella cooperative agreement, CDC would provide funding, as available, in support of a set of strategies that target prevention and control of emerging and re-emerging infectious diseases, including COVID-19. Collaborative activities would extend from the following program strategies: 1. DISSEMINATE AND ADOPT – Support CDC in the dissemination and adoption or implementation of guidance, clinical guidelines, and best practices for the prevention and control of emerging and re-emerging infectious diseases. 2. INFORM AND ADAPT – Inform and support CDC in the development and adaptation of guidance, tools, and best practices, including tailoring existing guidance to the needs of specific patient populations , clinical specialties, and workplace industry sectors. 3. TARGET AND TRAIN – Engage frontline personnel and lead training in CDC best practices for the broader workforce supporting the prevention and control of emerging and re-emerging infectious diseases. Target guidance and tools to better reach higher risk communities and reduce disease spread in targeted workplaces. 4. INTEGRATE AND EXTEND – Develop integrated and cross-sub-specialty networks for information sharing, problem-solving, and sharing of promising practices, including the development of rapid or living learning networks. Extend networks to reach vulnerable or hard-to-reach populations. 5. EVALUATE AND IMPROVE – Evaluate the impact and effectiveness of strategies for improved infection prevention and control practices. Implement continuous improvement by assessing and monitoring performance metrics related to prevention programs and program strategy.